Archive for the ‘business’ category

Dec 10, 2018

Bioquark Inc. — Bold Moves Podcast — Ira Pastor

Posted by in categories: aging, bioengineering, biotech/medical, business, DNA, finance, futurism, genetics, innovation, life extension

Dec 9, 2018

Artificial Intelligence Conference in San Francisco 2018

Posted by in categories: business, robotics/AI

Learn how to incorporate AI into real world projects using the latest tools and applications, and how AI can to add value to your business.

Read more

Dec 8, 2018

Regenerage — SMX Radio — The Net of Regenerative Medicine — Bioquark

Posted by in categories: aging, bioengineering, biotech/medical, business, disruptive technology, DNA, finance, futurism, genetics, life extension
Dr. Joel I. Osorio of RegenerAge Clinic on SMX Radio broadcasting from the Colonia Santa María la Ribera neighborhood of Mexico City -
“LAS NETAS DE LA MEDICINA REGENERATIVA” (The Net of Regenerative Medicine)

Continue reading “Regenerage — SMX Radio — The Net of Regenerative Medicine — Bioquark” »

Dec 7, 2018

Patent talk: Apple concept features earbuds that can be worn interchangeably

Posted by in categories: business, privacy

Are we about to see Apple reaching an even newer gold standard in ear buds? Apple has a patent for AirPods with built in biometrics. It’s being called “universal” because the idea calls for ear pods that can be worn in either ear. That would mean no more left-right business.

Much of the tech news coverage is focusing on the “interchangeable” aspect of the concept. 9to5Mac’s Alex Allegro said interchangeable earbuds “equipped with ‘at least one’ biometric sensor, which could detect left/right ear placement and accordingly adjust audio.” He assessed the potential advantages as “evolving AirPods from a separate left / right unit to a single component,” which could lower costs and simplify getting a replacement AirPod.

If the are interchangeable, then it is a big deal in terms of user satisfaction. OK, the product is popular now but The Verge reminds us that the AirPod is not a perfect fit for everyone. Nick Statt: “Due to the shape of some people’s inner ear, the headphones simply don’t fit every possible ear shape well.”

Continue reading “Patent talk: Apple concept features earbuds that can be worn interchangeably” »

Dec 7, 2018

Satellites may connect the entire world to the internet

Posted by in categories: business, internet, satellites

But business challenges and technical problems remain.

Read more

Dec 7, 2018

Distributed, decentralized, and democratized artificial intelligence

Posted by in categories: business, economics, robotics/AI, singularity

The accelerating investment in artificial intelligence has vast implications for economic and cognitive development globally. However, AI is currently dominated by an oligopoly of centralized mega-corporations, who focus on the interests of their stakeholders. There is a now universal need for AI services by businesses who lack access to capital to develop their own AI services, and independent AI developers lack visibility and a source of revenue. This uneven playing field has a high potential to lead to inequitable circumstances with negative implications for humanity. Furthermore, the potential of AI is hindered by the lack of interoperability standards. The authors herein propose an alternative path for the development of AI: a distributed, decentralized, and democratized market for AIs run on distributed ledger technology. We describe the features and ethical advantages of such a system using SingularityNET, a watershed project being developed by Ben Goertzel and colleagues, as a case study. We argue that decentralizing AI opens the doors for a more equitable development of AI and AGIt will also create the infrastructure for coordinated action between AIs that will significantly facilitate the evolution of AI into true AGI that is both highly capable and beneficial for humanity and beyond.

Read more

Dec 6, 2018

AI is not “magic dust” for your company, says Google’s Cloud AI boss

Posted by in categories: business, robotics/AI


Andrew Moore says getting the technology to work in businesses is a huge challenge.

Read more

Dec 6, 2018

The Welcome Crypto-Currency Crash

Posted by in categories: business, futurism

The Crypto Crash can lead to positive change for the future.

The ongoing crash in the Crypto-Currency Market is a breath of fresh air. I am sorry for the innocent people who are getting burned to a crisp but this crash is a necessary evil for a long list of reasons. The main benefit of this crash will be the institutional investors should be gone and simply that is the most awesome thing that could happen for the Crypto-Currency Market.

A number of the institutional investors and the strip miners have a negative impact on the Crypto-Currency markets. These two factions are not in the business to benefit Crypto-Currencies but to extract the maximum amount of profit from the venture. This is something I have said for years, mind you, not a single soul has listened to me, but it has been and will continue to be a simple honest truth. If Crypto is the survive the apocalypse, changes will have to be made.

Continue reading “The Welcome Crypto-Currency Crash” »

Dec 5, 2018

Bioquark — Electroceuticals — Real Bodies

Posted by in categories: aging, bioengineering, biotech/medical, business, DNA, futurism, genetics, innovation, neuroscience, science
Stefania De Matteo of HealthQe at Real Bodies Milan giving an overview of some of the new bio-physical tools ( being developed for a 2019 biotech world
With major pharma companies like GSK entering the “electro-ceuticals” space (and groups like RegenerAge Clinic beginning to utilize them in combinatorial protocols) we are seeing a re-emergence of these century old principles back into the mainstream bio-medical discussion

Continue reading “Bioquark — Electroceuticals — Real Bodies” »

Dec 4, 2018

“Is curing patients a sustainable business model?” Goldman Sachs analysts ask

Posted by in categories: bioengineering, biotech/medical, business, genetics, sustainability

Analyst Salveen Richter and colleagues laid it out:

The potential to deliver “one shot cures” is one of the most attractive aspects of gene therapy, genetically engineered cell therapy, and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies… While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.

For a real-world example, they pointed to Gilead Sciences, which markets treatments for hepatitis C that have cure rates exceeding 90 percent. In 2015, the company’s hepatitis C treatment sales peaked at $12.5 billion. But as more people were cured and there were fewer infected individuals to spread the disease, sales began to languish. Goldman Sachs analysts estimate that the treatments will bring in less than $4 billion this year.

Continue reading “‘Is curing patients a sustainable business model?’ Goldman Sachs analysts ask” »

Page 1 of 10812345678Last